Taiwan Preterm Infant Database: Analysis and Comparison of Birth Conditions and Exploration of Prognostic Factors
1 other identifier
observational
6,000
1 country
1
Brief Summary
The purpose of this study is to conduct a long-term follow-up of preterm infants with different birth conditions, aiming to provide data and resources for future care and to identify predictive and influencing factors related to their functional development over time. It is hypothesized that (1) preterm infants with varying birth conditions, such as birth weight and gestational age, will exhibit different developmental outcomes, and that the establishment of a Taiwan-specific preterm infant database is essential due to the lack of comprehensive local data and ethnic variations in gestational patterns; and (2) neonatal factors, including gestational age, birth weight, and postnatal complications (e.g., pneumonia, seizures, hypoxia), serve as potential risk factors influencing later developmental trajectories.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
August 29, 2025
CompletedFirst Posted
Study publicly available on registry
November 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedNovember 20, 2025
August 1, 2025
4 years
August 29, 2025
November 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Bayley-III Cognitive Composite Score
Standardized cognitive domain score from the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III). Scale range: higher scores indicate better cognitive development.
Baseline
Bayley-III Language Composite Score
Standardized language domain score from the Bayley-III. Scale range: higher scores indicate better language development.
Baseline
Bayley-III Motor Composite Score
Standardized motor domain score from the Bayley-III. Scale range: higher scores indicate better motor development.
Baseline
Head Circumference
Head circumference measured in centimeters (cm).
Baseline
Body Length
Body length measured in centimeters (cm).
Baseline
Body Weight
Body weight measured in kilograms (kg).
Baseline
Neurological Examination Score
Results from standardized neurological assessment. Scale range: higher scores indicate better neurological function.
Baseline
Mobility Ability Score
Functional mobility assessed using age-appropriate developmental checklist. Scale range: higher scores indicate greater independence.
Baseline
Presence of Medical Complications/Comorbidities
Recorded as a binary variable (Yes/No). Unit: Proportion (%)
Baseline
Rehabilitation Participation
Frequency of rehabilitation sessions per week based on clinical records. Unit: Sessions per week
Baseline
Study Arms (3)
birth weight group
The cases were subdivided into three groups based on birth weight: the extremely low birth weight group (\<1000 g), the very low birth weight group (1000-1500 g), and the low birth weight group (1500-2500 g).
gestational age group
The cases were subdivided into four groups based on gestational age: the extremely preterm group (\<28 weeks), the early preterm group (28-32 weeks), the moderate preterm group (32-34 weeks), and the late preterm group (34-37 weeks).
combined comparison group
The cases were subdivided into twelve groups based on the cross-classification of birth weight and gestational age.
Interventions
No Intervention: Observational Cohort
Eligibility Criteria
Control and experimental group
You may qualify if:
- Born \<37 weeks.
- Age 0-3 years.
- Stable condition with regular outpatient follow-up, medication, and rehabilitation.
You may not qualify if:
- Acute illness (e.g., infection).
- Conditions affecting neurodevelopment (e.g., cerebral palsy, severe complications, pneumonia, traumatic brain injury).
- Chromosomal abnormalities.
- Full-term Cases (Control Group)
- Born at full term.
- Age 0-3 years.
- No disease affecting neurodevelopment.
- Caregiver consent and cooperation.
- Medical diagnoses affecting neurodevelopment (e.g., traumatic brain injury).
- Neurodevelopmental disorders.
- Sensory disorders.
- Chromosomal abnormalities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chang Gung Memorial Hospital
Taoyuan District, 333, Taiwan
Biospecimen
Samples Without DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Chia-Ling Chen, MD, PhD
Chang Gung Memorial Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 4 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2025
First Posted
November 20, 2025
Study Start
March 1, 2022
Primary Completion
February 28, 2026
Study Completion
February 28, 2026
Last Updated
November 20, 2025
Record last verified: 2025-08